Department of Urology, Clinique Pasteur, Toulouse, France.
Department of Anaesthesiology and Critical Care, Lariboisière University Hospital, ECSTRA Team, CRESS, Epidemiology and Statistics Center, and University Denis Diderot, Paris, France.
J Urol. 2016 Apr;195(4 Pt 1):1027-32. doi: 10.1016/j.juro.2015.10.080. Epub 2015 Oct 17.
We compare patient outcomes after 180 W XPS™ GreenLight™ photoselective vaporization of the prostate and GreenLight laser enucleation of the prostate used to surgically manage benign prostatic obstruction.
Two groups of 60 consecutive patients with enlarged glands (greater than 80 ml) underwent GreenLight laser prostate enucleation or photoselective prostate vaporization (performed by the same surgeon and including the learning curve) and were retrospectively evaluated. Perioperative data from both groups were compared.
The operative time was significantly shorter in the GreenLight laser prostate enucleation group (60 vs 82 minutes, p <0.0001). Complication rates were comparable between the groups. At 2 months the rate of urinary incontinence was significantly higher in the GreenLight laser prostate enucleation group (25% vs 3.4%, p <0.0001) but incontinence rates were similar at 6 months (3.4% vs 0%, p=0.50). At 6 months International Prostate Symptom Score quality of life and post-void residual urine volume had similarly decreased in the 2 groups after the procedure (compared to baseline), whereas the maximum urinary flow rate had greatly improved, significantly favoring the GreenLight laser prostate enucleation group (+78% vs +64%, p <0.0001). Prostate size and prostate specific antigen reductions were significantly higher in the GreenLight laser prostate enucleation group (74% vs 57%, p <0.0001 and 67% vs 40%, respectively, p=0.007). The unplanned hospital readmission rates were similar in both groups (16.7% vs 6.7%, p=0.16).
Photoselective vaporization of the prostate and GreenLight laser enucleation of the prostate are safe and provide satisfactory short-term functional outcomes in patients with a prostate volume greater than 80 ml. However, the surgical time was longer in the photoselective prostate vaporization group, which also had a higher rate of unplanned hospital readmission, and lower decreases in prostate specific antigen and prostate size.
我们比较了 180W XPS™ 绿激光前列腺选择性汽化术和绿激光前列腺剜除术治疗良性前列腺梗阻的患者结局。
两组各 60 例前列腺体积增大(大于 80ml)患者接受了绿激光前列腺剜除术或绿激光前列腺选择性汽化术(由同一位外科医生完成,包括学习曲线),并进行回顾性评估。比较两组患者的围手术期数据。
绿激光前列腺剜除术组的手术时间明显更短(60 分钟 vs 82 分钟,p<0.0001)。两组并发症发生率相似。术后 2 个月,绿激光前列腺剜除术组尿失禁发生率明显更高(25% vs 3.4%,p<0.0001),但 6 个月时两组尿失禁发生率相似(3.4% vs 0%,p=0.50)。术后 6 个月,两组国际前列腺症状评分(IPSS)生活质量和残余尿量均明显下降(与基线相比),而最大尿流率均显著改善,绿激光前列腺剜除术组改善更明显(+78% vs +64%,p<0.0001)。绿激光前列腺剜除术组前列腺体积和前列腺特异性抗原(PSA)的降低更为显著(74% vs 57%,p<0.0001和 67% vs 40%,p=0.007)。两组患者的非计划性住院再入院率相似(16.7% vs 6.7%,p=0.16)。
绿激光前列腺选择性汽化术和绿激光前列腺剜除术治疗前列腺体积大于 80ml 的患者安全有效,可获得满意的短期功能结局。然而,绿激光前列腺选择性汽化术的手术时间较长,且非计划性住院再入院率较高,前列腺特异性抗原和前列腺体积的降低也较少。